Megan Atkins
Senior Scientist Pfizer
Seminars
Monday 3rd November 2025
Investigating Non-Clinical Mechanism Characterization & Impact of PDL1V on the Immune Complement of the Periphery & TME
10:00 am
- Exploring non-clinical evaluation of the unique characteristics of PDL1V, a PD-L1-targeting vedotin ADC
- Understanding PDL1V impact on immunosuppressive cells in the TME
- Assessing PDL1V impact on immunoresponsive cells needed for natural anti-tumor immunity activity
